ArticleHaematologica2024

Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.

Margarita Maurer-Granofszky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.